Clinical Trials in Linfen, Shanxi

16 recruiting

Showing 114 of 14 trials

Recruiting
Phase 2

A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

Arthritis, Rheumatoid
Merck Sharp & Dohme LLC182 enrolled62 locationsNCT07176390
Recruiting
Phase 3

A Multicentre, Randomised, Double-blind, Placebo-parallel Controlled Phase Ⅲ Clinical Trial Evaluating the Efficacy and Safety of BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Within 3 Hours of Onset.

AIS
Biocells (Beijing) Biotech Co.,Ltd1,112 enrolled9 locationsNCT07520565
Recruiting
Phase 3

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Primary Sjogrens Disease
argenx580 enrolled304 locationsNCT06684847
Recruiting
Phase 2

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

Pulmonary Disease, Chronic Obstructive
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.195 enrolled29 locationsNCT07252908
Recruiting
Phase 2

Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Rheumatoid Arthritis (RA)
Toll Biotech Co. Ltd. (Beijing)24 enrolled6 locationsNCT07408024
Recruiting
Not Applicable

Neuroendoscopy-assisted Drainage Versus Burr Hole Drainage for Chronic Subdural Hematoma

Chronic Subdural Hematoma
Beijing Tiantan Hospital770 enrolled24 locationsNCT07144423
Recruiting
Phase 3

JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Adenocarcinoma.

Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Shanghai Junshi Bioscience Co., Ltd.560 enrolled68 locationsNCT07284134
Recruiting
Phase 3

Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

Acute Ischemic Stroke
Shanghai Hutchison Pharmaceuticals Limited1,096 enrolled1 locationNCT07241520
Recruiting
Phase 2

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke
Kunming Pharmaceuticals, Inc.300 enrolled23 locationsNCT07279493
Recruiting
Phase 2

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Gout FlareAcute Gouty ArthritisGout Flares+1 more
Atom Therapeutics Co., Ltd380 enrolled38 locationsNCT07145229
Recruiting

A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography

Artificial Intelligence (AI)Cardiovascular Diseases (CVD)Echocardiography+1 more
First Hospital of China Medical University1,600 enrolled37 locationsNCT07133516
Recruiting
Phase 3

Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke (SHINY)

Ischemic Stroke, Acute
Beijing Tiantan Hospital1,380 enrolled82 locationsNCT06157502
Recruiting
Phase 3

Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy.

Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.518 enrolled71 locationsNCT05922345
Recruiting
Phase 3

A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection

Tetanus
Genrix (Shanghai) Biopharmaceutical Co., Ltd.582 enrolled20 locationsNCT06635798